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CORRESPONDENCE

Letter: Surgical Management of Brain Tumor
Patients in the COVID-19 Era
To the Editor:
The “coronavirus disease 2019” or COVID-19, caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
(Figure), has resulted in a worldwide pandemic and critically
burdened healthcare systems. We aim at establishing guidelines
regarding optimal surgical decision-making for treating brain
tumor patients in the COVID-19 era.

INTRACRANIAL TUMOR SURGICAL CASE
STRATIFICATION
Decisions regarding surgical intervention in this resourcescarce time must undergo rigorous ethical and clinical evaluation.
Except in emergency cases, we advocate using multidisciplinary
conferences to gather consensus regarding surgical urgency.1-4
Table 1 outlines our stratification used to guide surgical timing.
Screening/Testing Guidelines
In regions with high baseline COVID-19 rates and available
testing, all patients should undergo testing as close as possible to
surgery. Some institutions recommend 2 tests given the relatively
high false-negative test rate.5 In regions where COVID-19 testing
is not readily available, all patients should be screened with a
questionnaire to assess the likelihood of active disease and prior
exposure. Positive-screened patients should undergo testing when
available or undergo 14-d preoperative quarantine. If testing

remains unavailable, enhanced personal protective equipment
(PPE) (Table 1) precautions should be considered.6 In institutions without routine testing availability and without high
rates of disease presence, those patients who screen negative may
likely proceed to the operating room with standard precautionary
measures.

GENERAL PERIOPERATIVE CRANIAL
PRECAUTIONS
Enhanced PPE should be utilized for these procedures in
patients who screen positive via questionnaire or testing. Only
essential staff should be permitted in the operating room.
Aerosolization of the virus prior to and during intubation remains
possible where it can deposit on fomites in the operating room, or
even possibly remain suspended in the air.7,8 All staff nonessential
to intubation should leave the room during intubation.

ENDOSCOPIC ENDONASAL PROCEDURES
Given the high viral load in the upper airway of infected
patients, aerosolization of SARS-CoV-2 may be extremely high
during sinonasal and upper airway procedures, particularly
when powered instruments (such as drills) are employed.9
The American Association of Otolaryngology—Head and
Neck Surgery (AAO-HNS) recommends deferring endoscopic
endonasal procedures unless emergent or until preoperative
COVID-19 testing can be performed.10
Several scenarios, including high-flow cerebrospinal fluid
(CSF) leak, pituitary apoplexy, and progressive neurological
deficits secondary to an enlarging sellar lesion, may be deemed
emergent. Per the AAO-HNS, all surgeries should be performed
using enhanced PPE, regardless of COVID-19 testing status.10
Strong consideration should be given to transcranial approaches
to the sella when feasible (Table 2).

PARANASAL SINUS INVOLVEMENT AND
MASTOID DRILLING DURING TRANSCRANIAL
SURGERY

FIGURE. Illustration of SARS-CoV-2, the virus that causes COVID-19.
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Given that the paranasal sinuses are in direct communication
with the upper airway, extreme caution should be exercised to
avoid sinus entry during transcranial surgery. Previous publications have reported coronavirus (although not specifically SARSCoV-2) involving the middle ear11,12 ; as mastoid drilling can
aerosolize the virus, surgical approaches involving mastoid drilling
should be either deferred if nonurgent or avoided in favor of safer
approaches.
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TABLE 1. Surgical Timing Recommendations Based on Brain Tumor Surgical Indications
Category/procedure
Emergent (performed as soon as possible)
• Impending herniation, hydrocephalus
Urgent (performed as soon as possible, 2 to 7 d)
• Suspicion for high-grade malignancy
• Rapidly progressive neurological deficits

Semiurgent (performed within 1 to 4 wk)
• Mild or asymptomatic brain lesions
• Benign or stable imaging (absence of edema, mass effect, midline
shift, etc)
• Delay in surgery may cause progression of neurological deficit or
disease

Recommendation
• Assume patient is COVID-19 positive
• Use enhanced PPEa
• Stabilize patient medically
• If COVID-19 testing available:
– proceed with surgery
– preoperative testing as close as possible to surgery
– quarantine until testing returns negative
– rapid testing the day of surgery if available
• If testing unavailable:
– assume patient is COVID-19 positive
– use enhanced PPEa
– only a minimum number of required staff permitted in the
operating room
• Stabilize patient medically
• If testing not widely available:
– preoperative testing as close as possible to surgery if the
patient screens negative and has been self-quarantined for 14 d
• If testing available:
– proceed with surgery following preoperative testing as close as
possible to surgery and quarantine until testing returns negative
– rapid testing the day of surgery if available
• Consider stereotactic radiosurgery as an alternative to open surgery
and traditional fractionated radiotherapy in equivocal cases to
preserve hospital resources and minimize risk of staff exposure

PPE, personal protective equipment; PAPR, powered air-purifying respirator.
a
Enhanced PPE defined as an N95 respirator with facial protection or PAPR, surgical bouffant/cap, gloves, and gown.

AWAKE CRANIOTOMIES
Although SARS-CoV-2 transmission during an awake
craniotomy has never been reported, there is a theoretically
high risk of viral transmission, as a laryngeal mask airway may

be repeatedly inserted and removed throughout the surgery and
virus particles may be transmitted while the patient is breathing
and speaking. It may be prudent to use nonawake strategies for
eloquent area mapping, such as asleep intraoperative electromyography.13 Biopsy rather than surgical resection with the speech

TABLE 2. High-Risk COVID-19 Transmission Brain Tumor Surgical Approach Recommendations
Surgical approach
Endoscopic endonasal
Awake craniotomy

Approaches requiring mastoid air cell drilling (ie, retrosigmoid
craniotomy, posterior petrosectomy)
Frontal craniotomies
Benign tumors that are at high risk for prolonged hospital stay
causing obstructive hydrocephalus
All high-risk surgical approaches

Recommendations
• Consider transcranial approach if feasible
• Consider asleep mapping with intraoperative electromyogram
mapping
• Consider biopsy only if near speech areas (Broca/Wernicke)
• Enhanced PPE for all staff even if negative COVID-19 testing due to
false-negative rate
• Avoid entering paranasal sinuses
• Consider CSF diversion with ETV or VPS and defer tumor resection
• Defer surgery if elective
• Enhanced PPE for all staff even if negative COVID-19 testing due to
false-negative rate
• Minimal staff in operating room at all times

CSF, cerebrospinal fluid; ETV, endoscopic third ventriculostomy; PPE, personal protective equipment; VPS, ventriculoperitoneal shunt.
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mapping of left fronto-temporal-insular gliomas should be
considered.

CONSUMPTION OF PPE AND HOSPITAL
RESOURCES
Neurosurgeons should maintain extreme vigilance with PPE.
For surgeries likely to result in prolonged hospitalization, surgical
staging may be prudent. If a smaller surgical intervention is
planned, the neurosurgeon should consider operating without
an assistant. Reflexive intensive care unit (ICU) care for postoperative craniotomy patients can likely be avoided following
most straightforward operations. Rapid discharges with close
telemedicine follow-up should be employed. For patients with
extensive preoperative neurological disability preventing early
home discharge, social services should be activated upon hospital
admission for swift rehab disposition. Expeditious but safe
discharges can conserve hospital beds for COVID-19 patients.

PATIENT AND CAREGIVER SUPPORT
Brain tumor patients are particularly vulnerable in the
COVID-19 era. Patients frequently suffer from neurological
and functional impairment, thus requiring support via family,
home nursing services, and physical, occupational, and speech
therapy, many of which cannot be currently delivered. Preoperative consideration of these issues is paramount.
Patients undergoing radiation and/or chemotherapy are
frequently immunosuppressed and are at exquisite risk for the
development of infection. As per National Cancer Institute
recommendations, patients should practice respiratory precautions, limit exposure to others, and have access to several weeks
of medications.14
Disclosures
The authors have no personal, financial, or institutional interest in any of the
drugs, materials, or devices described in this article. Dr Zacharia is a member
of the NICO Corporation Speakers Bureau and is a consultant for Medtronic
Incorporated.

Brad E. Zacharia, MD, MS ∗ ‡
Daniel G. Eichberg, MD §
Michael E. Ivan, MD, MBS § ¶
Simon Hanft, MD ||
John A. Boockvar, MD#
Huseyin Isildak, MD ∗∗
Alireza Mansouri, MD, MSc ∗ ‡
Ricardo J. Komotar, MD § ¶
Randy S. D’Amico, MD#
∗
Department of Neurosurgery
The Pennsylvania State University
College of Medicine
Hershey, Pennsylvania

NEUROSURGERY

‡

Penn State Cancer Institute
Hershey, Pennsylvania
§
Department of Neurosurgery
University of Miami
Miami, Florida
¶
Sylvester Comprehensive Cancer Center
Miami, Florida
||
Department of Neurosurgery
Rutgers-Robert Wood Johnson Medical School
New Brunswick, New Jersey
#
Department of Neurosurgery
Lennox Hill Hospital/Northwell Health
New York, New York
∗∗
Department of Otolaryngology—Head and Neck Surgery
The Pennsylvania State University
College of Medicine
Hershey, Pennsylvania

REFERENCES
1. Eichberg DG, Shah AH, Luther EM, et al. Letter: academic neurosurgery
department response to COVID-19 pandemic: the University of Miami/Jackson
Memorial Hospital model. Neurosurgery. 2020.
2. Zoia C, Bongetta D, Veiceschi P, et al. Neurosurgery during the COVID19 pandemic: update from Lombardy, Northern Italy. Acta Neurochir
(Wien). published online: March 28, 2020 (doi:10.1007/s00701-02004305-w).
3. Tan YT, Wang JW, Zhao K, et al. Preliminary recommendations for surgical
practice of neurosurgery department in the central epidemic area of 2019
coronavirus infection. Curr Med Sci. published online: March 26, 2020
(doi:10.1007/s11596-020-2173-5).
4. Burke JF, Chan AK, Mummaneni V, et al. Letter: the coronavirus disease 2019
global pandemic: a neurosurgical treatment algorithm. Neurosurgery. published
online: 2020 (doi:10.1093/neuros/nyaa116).
5. Wang Y, Kang H, Liu X, Tong Z. Combination of RT-qPCR testing and clinical
features for diagnosis of COVID-19 facilitates management of SARS-CoV-2
outbreak. J Med Virol. (doi:10.1002/jmv.25721).
6. Saadi RA, Bann DV, Patel VA, Goldenberg D, May J, Isildak H. A commentary
on safety precautions for otologic surgery during the COVID-19 pandemic.
Otolaryngol Head Neck Surg. In Press.
7. Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A.
Consensus guidelines for managing the airway in patients with COVID19: guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and
the Royal College of Anaesthetists. Anaesthesia. published online: March 27
(doi:10.1111/anae.15054).
8. Cheung JC-H, Ho LT, Cheng JV, Cham EYK, Lam KN. Staff safety during
emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med.
2020;8(4):PE19.
9. Vukkadala N, Qian ZJ, Holsinger FC, Patel ZM, Rosenthal E. COVID-19 and
the otolaryngologist—preliminary evidence-based review. Laryngoscope. published
online: March 26, 2020 (doi:10.1002/lary.28672).
10. American Academy of Otolaryngology—Head and Neck Surgery.
Academy Supports CMS, Offers Specific Nasal Policy. March 18, 2020.
https://www.entnet.org/content/academy-supports-cms-offers-specific-nasalpolicy. Accessed March 20, 2020.
11. Pitkaranta A, Jero J, Arruda E, Virolainen A, Hayden FG. Polymerase
chain reaction-based detection of rhinovirus, respiratory syncytial virus,
and coronavirus in otitis media with effusion. J Pediatr. 1998;133(3):
390-394.
12. Pitkaranta A, Virolainen A, Jero J, Arruda E, Hayden FG. Detection of rhinovirus,
respiratory syncytial virus, and coronavirus infections in acute otitis media by

VOLUME 0 | NUMBER 0 | 2020 | 3

CORRESPONDENCE

reverse transcriptase polymerase chain reaction. Pediatrics. 1998;102(2 Pt 1):291295.
13. Yingling CD, Ojemann S, Dodson B, Harrington MJ, Berger MS.
Identification of motor pathways during tumor surgery facilitated by
multichannel electromyographic recording. J Neurosurg. 1999;91(6):
922-927.
14. National Cancer Institute. Coronavirus: What People With Cancer Should
Know. 2020. https://www.cancer.gov/contact/emergency-preparedness/coronavirus.
Accessed April 3, 2020.

4 | VOLUME 0 | NUMBER 0 | 2020

Acknowledgments
We would like to thank Roberto Suazo for contributing original high-quality
artwork.
C 2020 by the Congress of Neurological Surgeons
Copyright 

10.1093/neuros/nyaa162

www.neurosurgery-online.com

